$15.190
-0.921 (-6.06%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ARCT Prediction & Forecast by Similar Chart Analysis
Alphio's ARCT stock price prediction model matches the current Arcturus Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.41 (+1.42%). The 1-week path is $15.49 (+1.95%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Arcturus Therapeutics Holdings Inc Stock?
Arcturus Therapeutics (ARCT) appears to be a good buy right now due to its recent price surge of over 60% driven by positive market sentiment and significant advancements in its mRNA technology. The current price of $15.19 is well below the average analyst price target of $21, indicating substantial upside potential. Additionally, the RSI of 77.92 suggests strong momentum, although it is approaching overbought territory. The main risk is the company's widening net loss of $23.8 million in Q2 2026, which highlights ongoing financial challenges.
ARCT stock price ended at $15.19 on Friday, after losing -6.06%
Arcturus Therapeutics Holdings Inc (ARCT) last closed at $15.19, losing -6.06%. These facts feed the 1-day and 1-week ARCT price prediction above.
Analyst Consensus
Arcturus Therapeutics Holdings Inc (ARCT): 1 buy, 1 hold, 1 sell. Outlook: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Arcturus Therapeutics Holdings Inc (ARCT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ARCT, ranked by similarity.
Seasonality analysis for ARCT
Historically the probability of a positive August return for ARCT is 44.44%. February offers the highest probability of a positive month at 77.59%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ARCT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $10.50 | $11.09 | $12.34 | -26.97% |
| Sep 2026 | $9.12 | $9.74 | $11.72 | -35.86% |
| Oct 2026 | $8.02 | $8.11 | $9.20 | -46.61% |
| Nov 2026 | $7.44 | $9.58 | $10.34 | -36.96% |
| Dec 2026 | $7.73 | $9.33 | $9.77 | -38.61% |
In 2026, Arcturus Therapeutics Holdings Inc (ARCT) is projected to range from $7.44 to $12.34.
Arcturus Therapeutics Holdings Inc 2026 monthly forecast
In Aug 2026, Arcturus Therapeutics Holdings Inc is projected to average $11.09, with a low of $10.50 and high of $12.34.
In Sep 2026, Arcturus Therapeutics Holdings Inc is projected to average $9.74, with a low of $9.12 and high of $11.72.
In Oct 2026, Arcturus Therapeutics Holdings Inc is projected to average $8.11, with a low of $8.02 and high of $9.20.
In Nov 2026, Arcturus Therapeutics Holdings Inc is projected to average $9.58, with a low of $7.44 and high of $10.34.
In Dec 2026, Arcturus Therapeutics Holdings Inc is projected to average $9.33, with a low of $7.73 and high of $9.77.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.